HYLG stock forecast, quote, news & analysis

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Elevance Health (NYSE:ELV).

The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P Health Care Select Sector Half BuyWrite Index. The index measures the performance of a partially covered call strategy that holds a theoretical portfolio of the securities of the Health Care Select Sector Index. The fund invests in the securities reflected in the index or in investments (including other ETFs) that have economic characteristics that are substantially identical to the economic characteristics of such component securities and cannot invest directly in the index itself. It is non-diversified.

The average market capitalization across the Global X Health Care Cvrd Cll&Gr ETF ETF is 89.09B. The market cap for tickers in the group ranges from 9.7B to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is HSIC at 9.7B.

The average weekly price growth across all stocks in the Global X Health Care Cvrd Cll&Gr ETF ETF was -5%. For the same ETF, the average monthly price growth was -6%, and the average quarterly price growth was -1%. DXCM experienced the highest price growth at 8%, while MRNA experienced the biggest fall at -21%.

The average weekly volume growth across all stocks in the Global X Health Care Cvrd Cll&Gr ETF ETF was 63%. For the same stocks of the ETF, the average monthly volume growth was 160% and the average quarterly volume growth was 133%